A trans-NIAID program to support investigator-initiated informatics and data science technology development, driven by critical research needs in infectious or immune-mediated disease research.
- Encourage greater emphasis on advancing the science of immune-mediated, and infectious-diseases informatics and data science research
- Serve current & emerging needs across immune-mediated, and infectious-disease research continuum
- Support integration of data-driven hypothesis generation
- Promote cross-program collaborations
- Provide flexible & sustainable support that aligns with stage of informatics technology and data science development
The companion funding opportunity announcements (FOAs) will support software development focused on computational methods and tools that can considerably improve acquisition, management, analysis, visualization, and dissemination of relevant data and/or knowledge in infectious or immune-mediated diseases. They include but are not limited to the following:
- Technologies for data/metadata management
- Methods for effective data annotation
- Methods and workflows for integration of heterogenous data
- Technologies to establish optimal linkages of data
- Tools to improve the data quality of data
- Data mining and modeling technologies
- Solutions for distributed analyses
- Methods to conduct data disambiguation including use of cryptographic methods to enable collaborative data use/analytics
Companion Funding Opportunities and Announcements
Three companion funding announcements to align with the stage of the software development:
- RFA-AI-21-035: Exploratory Data Science Methods and Algorithm Development (R21)
- RFA-AI-21-020: Early-stage Development of Data Science Technologies (U01)
- RFA-AI-21-021: Enhancement or Sustainment of Data Science Tools (U24)
Steve Tsang, PhD
Frequently Asked Questions
The three announcements address different stages in the technology development continuum – R21 (exploratory research), U01 (early-stage development) and U24 (enhancement or sustainment).
Choose RFA-AI-21-035 (R21) if your proposed project focuses on developing innovative and novel methods and algorithms with the potential for significant value to immune-mediated or infectious disease research.
Choose RFA-AI-21-020 (U01) if your proposed project focuses on initial tool development or significant modification of existing tools for new applications for immune-mediated or infectious disease research.
Choose RFA-AI-21-021 (U24) if you have developed an informatics technology resource with an established user community and your application focuses on the enhancement and/or sustainment of this technology resource for immune-mediated or infectious-disease research.